HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis E
- Focus Therapeutic Use
- Acronyms HepNet Pilot Trial; HepNet-SofE study
- 04 Dec 2017 Planned End Date changed from 1 Dec 2018 to 1 Mar 2019.
- 04 Dec 2017 Planned primary completion date changed from 1 Sep 2018 to 1 Dec 2018.
- 04 Dec 2017 Status changed from not yet recruiting to recruiting.